These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32187044)

  • 41. Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck.
    Agaimy A; Dermawan JK; Leong I; Stoehr R; Swanson D; Weinreb I; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2022 Dec; 61(12):701-709. PubMed ID: 35766997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature.
    Yasuda T; Perry KD; Nelson M; Bui MM; Nasir A; Goldschmidt R; Gnepp DR; Bridge JA
    Hum Pathol; 2009 Mar; 40(3):341-8. PubMed ID: 18973919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel SRF-ICA1L Fusions in Cellular Myoid Neoplasms With Potential For Malignant Behavior.
    Suurmeijer AJ; Dickson BC; Swanson D; Sung YS; Zhang L; Antonescu CR
    Am J Surg Pathol; 2020 Jan; 44(1):55-60. PubMed ID: 31478943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.
    de Traux De Wardin H; Cyrta J; Dermawan JK; Guillemot D; Orbach D; Aerts I; Pierron G; Antonescu CR
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23232. PubMed ID: 38607246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.
    Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR
    Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
    Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
    Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation.
    Mehra S; de la Roza G; Tull J; Shrimpton A; Valente A; Zhang S
    Diagn Mol Pathol; 2008 Mar; 17(1):14-20. PubMed ID: 18303411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas.
    Kaleta M; Wakulińska A; Karkucińska-Więckowska A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Łastowska M
    Diagn Pathol; 2019 Sep; 14(1):103. PubMed ID: 31493794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells.
    Yoshida H; Miyachi M; Sakamoto K; Ouchi K; Yagyu S; Kikuchi K; Kuwahara Y; Tsuchiya K; Imamura T; Iehara T; Kakazu N; Hojo H; Hosoi H
    Oncogene; 2014 Dec; 33(49):5601-8. PubMed ID: 24213582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.
    Dehner CA; Broski SM; Meis JM; Murugan P; Chrisinger JSA; Sosa C; Petersen M; Halling KC; Gupta S; Folpe AL
    Mod Pathol; 2023 Oct; 36(10):100271. PubMed ID: 37422156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma.
    Pandey PR; Chatterjee B; Olanich ME; Khan J; Miettinen MM; Hewitt SM; Barr FG
    J Pathol; 2017 Apr; 241(5):626-637. PubMed ID: 28138962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
    Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
    Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Gallego S; Zanetti I; Orbach D; Ranchère D; Shipley J; Zin A; Bergeron C; de Salvo GL; Chisholm J; Ferrari A; Jenney M; Mandeville HC; Rogers T; Merks JHM; Mudry P; Glosli H; Milano GM; Ferman S; Bisogno G;
    Cancer; 2018 Aug; 124(15):3201-3209. PubMed ID: 29797665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative genomic hybridization: the profile of chromosomal imbalances in rhabdomyosarcoma].
    Li QX; Liu CX; Chun CP; Qi Y; Chang B; Nong WX; Yao ES; Li HA; Li F
    Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):536-41. PubMed ID: 19094465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma.
    Xie Z; Babiceanu M; Kumar S; Jia Y; Qin F; Barr FG; Li H
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13126-13131. PubMed ID: 27799565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.
    Hibbitts E; Chi YY; Hawkins DS; Barr FG; Bradley JA; Dasgupta R; Meyer WH; Rodeberg DA; Rudzinski ER; Spunt SL; Skapek SX; Wolden SL; Arndt CAS
    Cancer Med; 2019 Oct; 8(14):6437-6448. PubMed ID: 31456361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric spindle cell/sclerosing rhabdomyosarcoma with
    Fang Z; Duan C; Wang S; Fu L; Yang P; Yu T; Deel MD; Lau LMS; Ma X; Ni X; Su Y
    Transl Pediatr; 2024 Jan; 13(1):178-191. PubMed ID: 38323177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
    Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
    Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rhabdomyosarcoma With
    Zhong P; Wei S; Xiao H; Zeng Y
    Int J Surg Pathol; 2024 Jun; 32(4):758-766. PubMed ID: 37545350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.